Collegium to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Collegium (Nasdaq: COLL) announced management will participate in three investor conferences in Nov–Dec 2025.

Jefferies London Healthcare Conference presentation: Nov 19, 2025 at 8:00 a.m. GMT in London; webcast available via the Investors section and replay archived for 90 days.

Piper Sandler 37th Annual Healthcare Conference fireside chat: Dec 2, 2025 at 2:30 p.m. ET in New York; webcast available via the Investors section and replay archived for 90 days.

Evercore Healthcare Conference: Dec 4, 2025 in Coral Gables, FL; details and webcasts available from the Investors section.

STOUGHTON, Mass., Nov. 12, 2025 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that its management will participate in the following investor conferences:

Jefferies London Healthcare Conference
Presentation Date and Time: Wednesday, November 19, 2025, at 8:00 a.m. GMT
London, UK

The presentation will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

Piper Sandler 37th Annual Healthcare Conference
Fireside Chat Date and Time: Tuesday, December 2, 2025, at 2:30 p.m. ET
New York, NY

The fireside chat will be webcast live and can be accessed from the Investors section of the Company's website: https://ir.collegiumpharma.com. A replay of the webcast will be archived on the Company's website for 90 days following the presentation.

Evercore Healthcare Conference
Thursday, December 4, 2025
Coral Gables, FL

About Collegium Pharmaceutical, Inc.
Collegium is building a leading, diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The Company has a leading portfolio of responsible pain management medications and a rapidly growing neuropsychiatry business driven by Jornay PM®, a differentiated treatment for ADHD. Collegium’s strategy includes growing its commercial portfolio, with Jornay PM as the lead growth driver, and deploying capital in a disciplined manner. Collegium’s headquarters are located in Stoughton, Massachusetts. For more information, please visit the Company’s website at www.collegiumpharma.com.

Investor Contacts:
Ian Karp
Head of Investor Relations
ir@collegiumpharma.com 

Danielle Jesse
Director, Investor Relations
ir@collegiumpharma.com 

Media Contact:
Cheryl Wheeler
Head of Corporate Communications
communications@collegiumpharma.com 

FAQ

When will Collegium (COLL) present at the Jefferies London Healthcare Conference?

The Collegium presentation is scheduled for Nov 19, 2025 at 8:00 a.m. GMT.

How can investors watch Collegium's (COLL) Piper Sandler fireside chat on Dec 2, 2025?

The fireside chat will be webcast live and accessible via Collegium's Investors section; a replay will be archived for 90 days.

Will Collegium (COLL) webcast its Evercore Healthcare Conference appearance on Dec 4, 2025?

The announcement states the company will participate at Evercore on Dec 4, 2025; webcast availability should be checked in the company's Investors section.

Where can I find replays of Collegium (COLL) investor presentations?

Replays are archived on Collegium's Investors website and retained for 90 days after each presentation.

Which dates should shareholders note for Collegium (COLL) investor events in late 2025?

Key dates are Nov 19, 2025 (Jefferies), Dec 2, 2025 (Piper Sandler), and Dec 4, 2025 (Evercore).